Search CORE

2 research outputs found

EMA Review of Daratumumab (Darzalex) for the Treatment of Adult Patients Newly Diagnosed with Multiple Myeloma

Author: Committee for Medicinal Products for Human Use European Medicines Agency. Darzalex‐H‐C‐4077‐II‐0011
Committee for Medicinal Products for Human Use European Medicines Agency. Darzalex‐H‐C‐4077‐II‐0029
Committee for Medicinal Products for Human Use European Medicines Agency. Darzalex‐H‐C‐4077‐II‐0030
Committee for Medicinal Products for Human Use European Medicines Agency. Darzalex‐H‐C‐4077‐II‐0032
Rajkumar SV
Telly Chi Sinha A
Publication venue: 'Wiley'
Publication date
Field of study

Reporting, Visualization, and Modeling of Immunogenicity Data to Assess Its Impact on Pharmacokinetics, Efficacy, and Safety of Monoclonal Antibodies

Author: A Kuriakose
A Smith
A Vultaggio
A Vultaggio
B Gorovits
B Rup
C Passey
C Pineda
Chaitali Passey
CIMZIA
D Bachelet
DARZALEX
DT Mytych
E Schmidt
ERBITUX
European Medicines Agency
European Medicines Agency
F Aubin
Food and Drug Administration
Food and Drug Administration
Food and Drug Administration
Food and Drug Administration
G Bajaj
G Shankar
GR Gunn 3rd
GS Pandey
H Yang
J Link
JJ Perez Ruixo
JM Sailstad
KD Ratanji
KEYTRUDA
Kinjal Sanghavi
KM Morrissey
L Diao
L Gibiansky
L Zhou
LL Lecluse
Manish Gupta
MG Tovey
N Casadevall
N Chirmule
OPDIVO
PA Calabresi
PI Creeke
RN Schuck
S Agrawal
Satyendra Suryawanshi
SG Banugaria
SK Singh
SM Tatarewicz
SP Menting
TECENTRIQ
WJ Pichler
YERVOY
YM Wang
YM Wang
Publication venue: 'American Association of Pharmaceutical Scientists (AAPS)'
Publication date
Field of study

core

core